Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 121

1.

CCR7 Sulfotyrosine Enhances CCL21 Binding.

Phillips AJ, Taleski D, Koplinski CA, Getschman AE, Moussouras NA, Richard AM, Peterson FC, Dwinell MB, Volkman BF, Payne RJ, Veldkamp CT.

Int J Mol Sci. 2017 Aug 25;18(9). pii: E1857. doi: 10.3390/ijms18091857.

2.

Solution structure of CCL21 and identification of a putative CCR7 binding site.

Love M, Sandberg JL, Ziarek JJ, Gerarden KP, Rode RR, Jensen DR, McCaslin DR, Peterson FC, Veldkamp CT.

Biochemistry. 2012 Jan 24;51(3):733-5. doi: 10.1021/bi201601k. Epub 2012 Jan 17.

3.

Common and biased signaling pathways of the chemokine receptor CCR7 elicited by its ligands CCL19 and CCL21 in leukocytes.

Hauser MA, Legler DF.

J Leukoc Biol. 2016 Jun;99(6):869-82. doi: 10.1189/jlb.2MR0815-380R. Epub 2016 Jan 4. Review.

PMID:
26729814
4.

Crystallographic Structure of Truncated CCL21 and the Putative Sulfotyrosine-Binding Site.

Smith EW, Lewandowski EM, Moussouras NA, Kroeck KG, Volkman BF, Veldkamp CT, Chen Y.

Biochemistry. 2016 Oct 11;55(40):5746-5753. Epub 2016 Sep 26.

5.

Fluorescently Tagged CCL19 and CCL21 to Monitor CCR7 and ACKR4 Functions.

Purvanov V, Matti C, Samson GPB, Kindinger I, Legler DF.

Int J Mol Sci. 2018 Dec 4;19(12). pii: E3876. doi: 10.3390/ijms19123876.

6.

Transferring the C-terminus of the chemokine CCL21 to CCL19 confers enhanced heparin binding.

Barmore AJ, Castex SM, Gouletas BA, Griffith AJ, Metz SW, Muelder NG, Populin MJ, Sackett DM, Schuster AM, Veldkamp CT.

Biochem Biophys Res Commun. 2016 Sep 2;477(4):602-606. doi: 10.1016/j.bbrc.2016.06.098. Epub 2016 Jun 21.

7.

Differences in Sulfotyrosine Binding amongst CXCR1 and CXCR2 Chemokine Ligands.

Moussouras NA, Getschman AE, Lackner ER, Veldkamp CT, Dwinell MB, Volkman BF.

Int J Mol Sci. 2017 Sep 3;18(9). pii: E1894. doi: 10.3390/ijms18091894.

8.

CCL19 with CCL21-tail displays enhanced glycosaminoglycan binding with retained chemotactic potency in dendritic cells.

Jørgensen AS, Adogamhe PE, Laufer JM, Legler DF, Veldkamp CT, Rosenkilde MM, Hjortø GM.

J Leukoc Biol. 2018 Aug;104(2):401-411. doi: 10.1002/JLB.2VMA0118-008R. Epub 2018 May 16.

PMID:
29768676
9.

Arrestin 3 mediates endocytosis of CCR7 following ligation of CCL19 but not CCL21.

Byers MA, Calloway PA, Shannon L, Cunningham HD, Smith S, Li F, Fassold BC, Vines CM.

J Immunol. 2008 Oct 1;181(7):4723-32.

10.

Differential ligand-signaling network of CCL19/CCL21-CCR7 system.

Raju R, Gadakh S, Gopal P, George B, Advani J, Soman S, Prasad TS, Girijadevi R.

Database (Oxford). 2015 Oct 26;2015. pii: bav106. doi: 10.1093/database/bav106. Print 2015.

11.

Chemokine (C‑C motif) ligand 21/C‑C chemokine receptor type 7 triggers migration and invasion of human lung cancer cells by epithelial‑mesenchymal transition via the extracellular signal‑regulated kinase signaling pathway.

Zhong G, Chen L, Yin R, Qu Y, Bao Y, Xiao Q, Zhang Z, Shen Y, Li C, Xu Y, Zou Z, Tian H.

Mol Med Rep. 2017 Jun;15(6):4100-4108. doi: 10.3892/mmr.2017.6534. Epub 2017 May 2.

12.

Biased signaling of G protein-coupled receptors - From a chemokine receptor CCR7 perspective.

Jørgensen AS, Rosenkilde MM, Hjortø GM.

Gen Comp Endocrinol. 2018 Mar 1;258:4-14. doi: 10.1016/j.ygcen.2017.07.004. Epub 2017 Jul 8. Review.

PMID:
28694053
13.

Dendritic cell chemotaxis in 3D under defined chemokine gradients reveals differential response to ligands CCL21 and CCL19.

Haessler U, Pisano M, Wu M, Swartz MA.

Proc Natl Acad Sci U S A. 2011 Apr 5;108(14):5614-9. doi: 10.1073/pnas.1014920108. Epub 2011 Mar 21.

14.

Combinatorial guidance by CCR7 ligands for T lymphocytes migration in co-existing chemokine fields.

Nandagopal S, Wu D, Lin F.

PLoS One. 2011 Mar 25;6(3):e18183. doi: 10.1371/journal.pone.0018183.

15.

The expression of chemokines CCL19, CCL21 and their receptor CCR7 in oral squamous cell carcinoma and its relevance to cervical lymph node metastasis.

Oliveira-Neto HH, de Souza PP, da Silva MR, Mendonça EF, Silva TA, Batista AC.

Tumour Biol. 2013 Feb;34(1):65-70. doi: 10.1007/s13277-012-0511-3. Epub 2012 Sep 14.

PMID:
22976543
16.

CCL21 chemokine regulates chemokine receptor CCR7 bearing malignant melanoma cells.

Takeuchi H, Fujimoto A, Tanaka M, Yamano T, Hsueh E, Hoon DS.

Clin Cancer Res. 2004 Apr 1;10(7):2351-8.

17.

ACKR4 on Stromal Cells Scavenges CCL19 To Enable CCR7-Dependent Trafficking of APCs from Inflamed Skin to Lymph Nodes.

Bryce SA, Wilson RA, Tiplady EM, Asquith DL, Bromley SK, Luster AD, Graham GJ, Nibbs RJ.

J Immunol. 2016 Apr 15;196(8):3341-53. doi: 10.4049/jimmunol.1501542. Epub 2016 Mar 14.

18.

Differential expression of CCL19 by DC-Lamp+ mature dendritic cells in human lymph node versus chronically inflamed skin.

Katou F, Ohtani H, Nakayama T, Nagura H, Yoshie O, Motegi K.

J Pathol. 2003 Jan;199(1):98-106.

PMID:
12474232
19.

Stimulation of osteoclast migration and bone resorption by C-C chemokine ligands 19 and 21.

Lee J, Park C, Kim HJ, Lee YD, Lee ZH, Song YW, Kim HH.

Exp Mol Med. 2017 Jul 21;49(7):e358. doi: 10.1038/emm.2017.100.

20.

A myriad of functions and complex regulation of the CCR7/CCL19/CCL21 chemokine axis in the adaptive immune system.

Comerford I, Harata-Lee Y, Bunting MD, Gregor C, Kara EE, McColl SR.

Cytokine Growth Factor Rev. 2013 Jun;24(3):269-83. doi: 10.1016/j.cytogfr.2013.03.001. Epub 2013 Apr 12. Review.

PMID:
23587803

Supplemental Content

Support Center